Clinical Trial Update: Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase (Phase 1) trial evaluated the combination of talimogene laherparepvec with atezolizumab in early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Imlygic (Talimogene laherparepvec)
• Tecentriq (atezolizumab)

Snippet

Sponsor: SOLTI Breast Cancer Research Group | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED